ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AMN vs MA // EV/EBITDA & P/E VALUATION

AMN Healthcare Services Inc (NYSE) VS. Mastercard Incorporated (NYSE) • 15-METRIC TALLY: AMN 2 — MA 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AMN VS. MA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AMN MA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 28.30% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -7.20% 33.50% -40.70 MA /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 29.2x — TIE /valuation <GO>
Free Cash Flow Yield 12.86% 3.08% +9.78 AMN /fcf-yield <GO>
Operating Margin -2.00% 57.60% -59.60 MA /operating-margins <GO>
Net Profit Margin -3.50% 45.60% -49.10 MA /net-margins <GO>
Revenue Growth (YoY) -8.50% 16.40% -24.90 MA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.49% -0.49 MA /dividend-safety <GO>
Altman Z-Score & Debt/Equity 2.76 11.17 -8.41 MA /balance-sheet <GO>
Piotroski F-Score Quality 5/9 8/9 -3.00 MA /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 75.9 68.8 +7.11 AMN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.90 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 31.2x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.82B $556.88B -$555.06B MA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AMN REV MA REV AMN GROSS % MA GROSS % AMN FCF MA FCF
FY 2025 $2.73B $32.79B 28.3% — $233.8M $17.16B
FY 2024 $2.98B $28.17B 30.8% — $239.5M $14.31B
FY 2023 $3.79B $25.10B — — $372.2M $10.85B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AMN // BETA —
MA // BETA 0.90